WEIGHT LOSS DRUGS ++++

WEIGHT LOSS DRUGS ABC News: Many Medicare Enrollees Can Get GLP-1 Drugs For $50 Starting In July More access to affordable weight-loss medications is coming this summer for adults on Medicare. Starting in July, certain Medicare enrollees can pay $50 a month for specific prescription GLP–1 medications, according to the Centers for Medicare and Medicaid Services. Medicare announced the pilot program for the popular weight loss medications on Wednesday. The Medicare GLP-1 Bridge program will run between July 1, 2026, and Dec. 31, 2027. (Yu, 5/7) https://abcnews.com/GMA/Wellness/medicare-enrollees-glp-1-drugs-50-starting-july/story?id=132738089&utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--8Uo4JCizm4gUWGDeTd-SFkA821s0jvPstR92LCq0tt9BfjluasotMf3Eca06am6KUHGUuB-Kw-Ai5oP1-bL8Uhq1e1A&_hsmi=417857248&utm_content=417857248&utm_source=hs_email Fierce Healthcare: Amazon Pharmacy To Offer Home Delivery For Novo's Ozempic Pill Amazon Pharmacy will make Novo Nordisk's Ozempic pill available for home delivery, the company announced Thursday. Per the announcement, Amazon customers will be able to secure the oral GLP-1 medication via same-day delivery or pickup within minutes at its kiosks in short order. The drug, which is approved to manage blood sugar in individuals with type 2 diabetes, was originally sold as Rybelsus but was recently rebranded to Ozempic by Novo. (Minemyer, 5/7) https://www.fiercehealthcare.com/retail/amazon-pharmacy-offer-home-delivery-novo-nordisks-ozempic-pill?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--n_hFT0ohBQJI88FTk35RCM0RxBUi8LFz1LQoefpcszSRFRUuY6BRODvOSnY7egbKJ377BW1qWzq-_8vu-Mh2LjrmKNg&_hsmi=417857248&utm_content=417857248&utm_source=hs_email The Washington Post: GLP-1s May Not Shrink Muscle Mass As Much As We Thought, Study Suggests Are GLP-1 weight-loss drugs hard on your muscles? That question has sparked controversy and concern among some scientists, doctors and the general public. Several large studies in recent years had suggested that people taking GLP-1 drugs such as Zepbound or Wegovy were losing outsize proportions of their muscle mass while also shedding body fat. In some of those studies, nearly 40 percent of people’s weight loss with GLP-1 drugs seemed to come from muscle, a much higher percentage than would be considered normal among people losing weight by dieting or other lifestyle changes. (Reynolds, 5/7) https://www.washingtonpost.com/wellness/2026/05/07/glp-1-muscles/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_Y64fS1Q16WAv0XQ_h10mUr790SgN1e8c1PhEoUL_uzG8bfgSCKzjqTr4xSmDxdTbqx2VZr6FNSZxDahzmL_mOaXsdWQ&_hsmi=417857248&utm_content=417857248&utm_source=hs_email MedPage Today: Teens With T1D, Obesity Reaped Benefits Of GLP-1s, Case Studies Suggest Two insulin-dependent adolescents with type 1 diabetes and obesity had metabolic improvements after starting a low-dose GLP-1 agent, a case series showed. (Monaco, 5/8) https://www.medpagetoday.com/endocrinology/type1diabetes/121164?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9jl7BuA55WTQXNxaJwEP_FNUUC4q9OZdo9ZtbK5_ajqP_FWZWZYNNGiFQ1X2iM16dcNOiLTkTrQ9bB9QDGXTMvQnJW7g&_hsmi=417857248&utm_content=417857248&utm_source=hs_email